Unknown

Dataset Information

0

Baicalin relieves neuropathic pain by regulating ?2-adrenoceptor levels in rats following spinal nerve injury.


ABSTRACT: In the present study, the ability of baicalin to relieve neuropathic pain due to spinal nerve ligation in rats was explored, and the relationship between baicalin and ?2-adrenoceptors (?2-AR) was determined. The neuropathic pain model was established by ligating the L5-L6 spinal nerves in Sprague-Dawley rats. Several ?2-AR antagonists were injected into the intramedullary sheath to evaluate the role of baicalin in neuropathic pain. The antagonists included nonselective ?2-AR antagonist idazoxan, ?2a-AR antagonist BRL 44408, ?2b-AR antagonist ARC 239 and ?2c-AR antagonist JP 1302. The rats were divided into an untreated control group, saline group, baicalin group and baicalin + ?2-AR antagonist groups. Paw withdrawal threshold (PWT) was tested to assess the level of pain felt by the rats. The levels of ?2-AR mRNA were tested by reverse transcription-quantitative PCR. Inflammatory factors, including tumor necrosis factor (TNF)-?, interleukin (IL)-6, IL-17 and IL-1?, were analyzed by ELISA. The histopathological changes were assessed by hematoxylin and eosin staining. Flow cytometry was used to examine the percentage of CD4+ peripheral blood mononuclear cells (PBMCs). Compared with the saline group, the PWT value increased after treating with baicalin. However, intrathecal injection of ?2-AR antagonist reversed the antinociceptive effects of baicalin. Compared with the saline group, the expression of ?2a-AR and ?2c-AR mRNA was upregulated significantly in the baicalin group (P<0.05). Levels of ?2-AR mRNA were also decreased in the baicalin + idazoxan group compared with the baicalin group (P<0.05). The levels of TNF-?, IL-6, IL-17 and IL-1? were raised after treatment with baicalin. In addition, baicalin treatment ameliorated the histological damage in the spinal cord. The percentage of CD4+ PBMCs was increased in the saline group compared with the control group (P<0.05). Compared with the baicalin group, the percentage of CD4+ PBMCs was raised after treatment with the ?2-AR antagonists. In conclusion, intrathecal injection of baicalin produced an antiallodynic effect in a spinal nerve ligation-induced neuropathic pain model. The mechanism may be related to the regulation of a2-AR expression.

SUBMITTER: Huang LJ 

PROVIDER: S-EPMC7401858 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Baicalin relieves neuropathic pain by regulating α<sub>2</sub>-adrenoceptor levels in rats following spinal nerve injury.

Huang Lan-Ji LJ   Jia Shu-Shan SS   Sun Xue-Hua XH   Li Xin-You XY   Wang Fei-Fei FF   Li Wei W   Jin Qing-Song QS  

Experimental and therapeutic medicine 20200717 3


In the present study, the ability of baicalin to relieve neuropathic pain due to spinal nerve ligation in rats was explored, and the relationship between baicalin and α<sub>2</sub>-adrenoceptors (α<sub>2</sub>-AR) was determined. The neuropathic pain model was established by ligating the L5-L6 spinal nerves in Sprague-Dawley rats. Several α<sub>2</sub>-AR antagonists were injected into the intramedullary sheath to evaluate the role of baicalin in neuropathic pain. The antagonists included nonsel  ...[more]

Similar Datasets

| S-EPMC6233159 | biostudies-literature
| S-EPMC5560278 | biostudies-other
| S-EPMC7177766 | biostudies-literature
2011-10-17 | E-GEOD-24982 | biostudies-arrayexpress
2011-10-18 | GSE24982 | GEO
| S-EPMC4504460 | biostudies-literature
2014-09-29 | E-GEOD-60033 | biostudies-arrayexpress
| S-EPMC5967156 | biostudies-literature
| S-EPMC3048571 | biostudies-literature
2008-03-31 | GSE10238 | GEO